Skip to main content

Table 1 Demographics and Indications

From: Propensity score adjusted comparison of three-factor versus four-factor prothrombin complex concentrate for emergent warfarin reversal: a retrospective cohort study

Variables PCC3 (n = 57) PCC4 (n = 23)
Characteristics
 Age (years)a 74.0 (62.0–80.0) 66.0 (57.0–82.0)
 Weight (kg)a 81.4 (72.1–94.4) 77.8 (64.7–97.8)
Sex, n (%)
 Male 36 (63.2%) 12 (52.2%)
 Female 21 (36.8%) 11 (47.8%)
Indication for warfarin, n (%)
 Atrial Arrhythmias 32 (56.1%) 8 (34.8%)
 DVT/PEb 7 (12.8%) 4 (17.4%)
 Valve replacement 6 (10.5%) 5 (21.7%)
 Ischemia CVA 4 (7.0%) 1 (4.3%)
 Other 8 (14.0%) 5 (21.7%)
Bleed type, n (%)
 Intracranial 31 (54.4%) 19 (82.6%)
 Gastrointestinal 10 (17.5%) 2 (8.7%)
 Other 16 (28.1%) 2 (8.7%)
  1. CVA cerebrovascular accident, DVT/PE deep vein thrombosis and/or pulmonary embolism, EWR emergent warfarin reversal, PCC3 3-factor prothrombin complex concentrate, PCC4 4-factor prothrombin complex concentrate
  2. aAge and Weight given as median (25th–75th percentiles)
  3. bProphylaxis or treatment